share_log

众生药业:公司暂无相关产品

Stock Star ·  Jan 14 08:30

证券之星消息,众生药业(002317)01月14日在投资者关系平台上答复投资者关心的问题。

投资者:众生药业有猴痘治疗药吗?
众生药业董秘:您好!公司暂无相关产品。谢谢!
投资者:公司昂拉地韦片抗甲流新药已经报审1年多了至今未批,非常不正常,中小投资者有知情权,究竟是什么原因?是隐瞒了产品的重大缺陷吗?公司当初公告说药效是磷酸奥司他韦的十几倍且副作用更小且是某知名专家领衔指导,很多投资者是奔着这款产品来的
众生药业董秘:您好,感谢您对公司的关注!公司不存在您所述的情况,目前昂拉地韦片正在审评审批阶段,并按照CDE要求正常推进中。谢谢!
投资者:昂拉地韦有没有收到 CDE 的发补通知?目前进展到哪一步了?
众生药业董秘:您好!目前昂拉地韦片正在审评审批阶段,并按照CDE要求正常推进中。谢谢!

以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 273

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.